Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Gastrointestinal Endoscopy|March 6, 2024
Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma (with video)Hyemin Kim, Jinho Jang, Jin Ho Choi, et al.
Biomarker Research|June 30, 2026
Malignant epithelial states drive immune dysfunction in ampulla of Vater carcinomaHyoung-Oh Jeong, Young Hoon Choi, Hyemin Kim, et al.
Anti-Cancer Drugs|October 16, 2009
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancerHyo Song Kim, Seong Yoon Yi, Hyun Jung Jun, et al.
Journal of Translational Medicine|October 18, 2023
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinomaYoungil Koh, Hyemin Kim, So Young Joo, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 23, 2024
Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic CancerJi Hye Min, Jeong Il Yu, Seong Hyun Kim, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2015
Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter studyTae Hyeon Kim, Tae Jun Song, Jin-Hyeok Hwang, et al.
British Journal of Cancer|October 31, 2023
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trialJung Hyun Jo, Yong-Tae Kim, Ho Soon Choi, et al.
Plos One|December 14, 2017
Risk factors associated with adverse events during endoscopic ultrasound-guided tissue samplingKwang Hyuck Lee, Eun Young Kim, Juhee Cho, et al.
Gut and Liver|May 7, 2018
Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter StudyTae-Hyeon Kim, Young-Sik Woo, Hyung-Ku Chon, et al.
Helicobacter|January 24, 2007
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in KoreaByeong Gwan Kim, Dong Ho Lee, Byong Duk Ye, et al.
Pageof 15